Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001209191-21-044980

Chief Commercial Officer gave up 5,151 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Wiley Matthew T. · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-06-30 Shares withheld for taxes : show line 1 in the form −5,151 $3.51 $18,080 109,246 D
Loading xslF345X03/doc4.xml…